declining-sales – Latest Health News

Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation

Apr 28, 2016

—

by

By Ben Hirschler and Leigh Thomas LONDON/PARIS (Reuters) – French drugmaker Sanofi went public with a $9.3 billion offer to buy Medivation on Thursday, setting up what could be a lengthy takeover fight after the U.S. cancer firm rebuffed its approaches. The decision to target Medivation marks a return to the biotech takeover trail for…

UBS, MPM team up on $471 million cancer fund to speed drug development

Apr 28, 2016

—

by

admin

in Latest News

(Corrects minimum commitment to $200,000 from $500,000 figure given by UBS on Wednesday) ZURICH (Reuters) – A $471 million UBS venture fund aims to generate annual returns “north of 10 percent” for its European and Asian investors by financing new cancer drugs, helping speed them from the lab to the point where drug companies buy…

Significant premium hikes expected under Obama health law

Apr 28, 2016

—

by

contributor

in Latest News

WASHINGTON (AP) — Expect insurers to seek significant premium increases under President Barack Obama's health care law, in a wave of state-level requests rippling across the country ahead of the political conventions this summer.

Sanofi pledges stable 2016 earnings

Feb 9, 2016

—

by

contributor

in Latest News

By Matthias Blamont and Noëlle Mennella PARIS (Reuters) – Sanofi said it expected stable earnings per share this year after reporting lower fourth-quarter income on Tuesday, hurt by declining sales of diabetes and cancer treatments and other prescription drugs. The French drugmaker, which is in the midst of a reorganisation to address falling sales of…

Tag: declining-sales

Sanofi launches $9.3 billion fight for U.S. cancer firm Medivation

UBS, MPM team up on $471 million cancer fund to speed drug development

Significant premium hikes expected under Obama health law

Sanofi pledges stable 2016 earnings